After the long emergency we all took a breath and imagined that the worst was over. Unfortunately, this is not the case and we risk paying dearly for this choice.
The unprecedented crisis caused by the pandemic has triggered an acceleration of the spread of new digital tools.
The discussion and enthusiasm that has been generated on telemedicine are focused on the possibility of remote visits and consultations and the care of patients at home. However, telemedicine is not just that.
One of the major limitations of the televisit is the difficulty of examining the patient’s main organs due to physical distance.
Philips has introduced a new generation of wearable biosensors for early detection of deterioration of the patient’s clinical condition, including clinical surveillance for COVID-19.
Phase two of Covid-19 will see a resumption of non-urgent medical activities that have been postponed due to the emergency and in order not to increase the spread of the infection within health care facilities – (Article published in AboutPharma May 2020).
A minimum reference model for the management of COVID-19 patients.
Digital innovation can play a key role in managing phases two and three of the Coronavirus. Let’s see the main areas of application.
An original place to place sensors to detect vital parameters. Continue reading
A tele-ICU platform is being implemented in Israel at the Sheba Medical Center and the Ichilov Hospital of Tel Aviv Sourasky Medical Center. Continue reading